GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
PNOYX
Price
$152.01
Change
-$2.62 (-1.69%)
Updated
Nov 13 closing price
Net Assets
6.65B
Interact to see
Advertisement

GFACX vs PNOYX

Header iconGFACX vs PNOYX Comparison
Open Charts GFACX vs PNOYXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
Putnam Sustainable Leaders Y
Price$152.01
Change-$2.62 (-1.69%)
VolumeN/A
Net Assets6.65B
GFACX vs PNOYX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. PNOYX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and PNOYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. PNOYX (6.65B). PNOYX pays higher dividends than GFACX: PNOYX (0.57) vs GFACX (0.00). GFACX was incepted earlier than PNOYX: GFACX (25 years) vs PNOYX (31 years). GFACX (1.36) is less costly to investors than PNOYX (0.62). GFACX is a more actively managed with annual turnover of: 25.00 vs. PNOYX (22.00). PNOYX has a lower initial minimum investment than GFACX: PNOYX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. PNOYX (1.18). GFACX return over 5 years is better than : 27.87 vs. PNOYX (24.83).
GFACXPNOYXGFACX / PNOYX
Total Expense Ratio1.360.62219%
Annual Report Gross Expense Ratio1.360.62219%
Fund Existence25 years31 years-
Gain YTD16.34311.413143%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets340B6.65B5,110%
Annual Yield % from dividends0.000.57-
Returns for 1 year4.611.18390%
Returns for 3 years56.1739.83141%
Returns for 5 years27.8724.83112%
Returns for 10 years75.78100.5475%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics